Related Experiment Video
Updated: Aug 11, 2026
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
An inflammatory pathomechanism for Parkinson's disease?
Christophe Wersinger1, Anita Sidhu
1Laboratory of Molecular Neurochemistry, Department of Pediatrics, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20007, USA.
Current Medicinal Chemistry
|March 7, 2006
Summary
Brain inflammation and immune responses may play a role in Parkinson's disease (PD) progression. Alpha-synuclein aggregates might activate microglia, causing chronic inflammation in PD patients.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Parkinson's disease (PD) involves dopaminergic neuron loss in the Substantia Nigra pars compacta (SNpc).
- Evidence suggests inflammatory and immune responses in PD brains, though human data is debated.
- Animal models show reactive astrocytosis and lymphocytic infiltration in the SNpc.
Purpose of the Study:
- To review current knowledge on neuroinflammation in human PD.
- To explore links between inflammation, immune reactions, and PD etiology (oxidative stress, toxins, injuries).
- To hypothesize the role of alpha-synuclein in microglial activation and chronic inflammation.
Main Methods:
- Literature review of existing studies on brain inflammation in PD.
- Analysis of potential links between inflammation and other PD pathophysiological mechanisms.
- Discussion of microglial cell activation and alpha-synuclein's role.
Main Results:
- PD is characterized by neurodegeneration and dopamine deficiency.
- Inflammatory and immune stigmata are observed in PD patients' brains and animal models.
- Alpha-synuclein aggregates may activate microglia, driving chronic inflammation and disease progression.
Conclusions:
- Neuroinflammation is a significant factor in Parkinson's disease.
- Alpha-synuclein aggregates are hypothesized to trigger sustained microglial activation and inflammation.
- Anti-inflammatory agents are being explored as potential adjuvant therapies for PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...